Roadmap for implementation of quality by design (QbD) for biotechnology products.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Trends in Biotechnology

• Publication date

  2009-09-01

• Fields of study

  Medicine, Business, Engineering

• Identifiers
  DOI 10.1016/j.tibtech.2009.06.006PMID 19647883
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monitoring of Biopharmaceutical Processes: Present and Future Approaches

  2009cited by this paper
• Quality by design for biopharmaceuticals

  2009cited by this paper
• ICH Harmonised Tripartite Guideline

  2009cited by this paper
• A Rational Approach for Setting and Maintaining Specifications for Biological and Biotechnology-Derived Products Part 1

  2008cited by this paper
• Considerations for Biotechnology Product Quality by Design

  2008cited by this paper
• QbD for Raw Materials

  2008cited by this paper
• How to Make the Business Case for Quality by Design

  2008cited by this paper
• The FDA critical path initiative and its influence on new drug development.

  2008cited by this paper
• PQLI Design Space

  2008cited by this paper
• Applications of Design Space for Biopharmaceutical Purification Processes

  2008cited by this paper
• Case Study on Definition of Process Design Space for a Microbial Fermentation Step

  2008cited by this paper
• Effect of Shear Stress on Intrinsic CHO Culture State and Glycosylation of Recombinant Tissue‐Type Plasminogen Activator Protein

  2008cited by this paper
• Toward biosimilar monoclonal antibodies

  2008cited by this paper
• Application of Quality by Design and Risk Assessment Principles for the Development of Formulation Design Space

  2008cited by this paper
• Application of Multivariate Data Analysis for Identification and Successful Resolution of a Root Cause for a Bioprocessing Application

  2008cited by this paper
• PQLI Definition of Criticality

  2008cited by this paper
• PQLI Key Topics - Criticality, Design Space, and Control Strategy

  2008cited by this paper
• Using a Risk Assessment Process to Determine Criticality of Product Quality Attributes

  2008cited by this paper
• Case study and application of process analytical technology (PAT) towards bioprocessing: II. Use of ultra-performance liquid chromatography (UPLC) for making real-time pooling decisions for process chromatography.

  2008cited by this paper
• Application of QbD Principles to Tangential Flow Filtration Operations

  2008cited by this paper
• Defining Process Design Space for Biotech Products: Case Study of Pichia pastoris Fermentation

  2008cited by this paper
• Case study and application of process analytical technology (PAT) towards bioprocessing: Use of on‐line high‐performance liquid chromatography (HPLC) for making real‐time pooling decisions for process chromatography

  2008cited by this paper
• Elements of Quality by Design in Development and Scale-Up of Freeze-Dried Parenterals

  2008cited by this paper
• Using Statistical Analysis for Setting Process Validation Acceptance Criteria for Biotech Products

  2007cited by this paper
• A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs

  2007cited by this paper
• Process Analytical Technology (PAT): batch-to-batch reproducibility of fermentation processes by robust process operational design and control.

  2007cited by this paper
• Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics.

  2007cited by this paper
• Validation and implementation of drug-dependent antibody assays in clinical trials for safety monitoring of patients dosed with roxifiban, an orally bioavailable glycoprotein IIb/IIIa antagonist.

  2007cited by this paper
• Application of Multivariate Analysis toward Biotech Processes: Case Study of a Cell‐Culture Unit Operation

  2007cited by this paper
• Quality by Design in the CMO Environment

  2007cited by this paper
• Design space for biotech products

  2007cited by this paper
• Effects of protein aggregates: An immunologic perspective

  2006cited by this paper
• Applying process analytical technology to biotech unit operations

  2006cited by this paper
• A Review of Process Analytical Technology (PAT) in the U.S.Pharmaceutical Industry

  2006cited by this paper
• Current and future issues in the manufacturing and development of monoclonal antibodies.

  2006cited by this paper
• Ollihoring to China : What should your model be?

  2006cited by this paper
• Assessing and managing risks in a GMP environment

  2005cited by this paper
• Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals

  2005cited by this paper
• Applications of process analytical technology to crystallization processes.

  2004cited by this paper
• Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products.

  2004cited by this paper

• Development and validation of a RP-HPLC method for Milrinone quantification using analytical quality by design principles: stability, precision, and method optimization

  2025cites this paper
• Mannitol in direct compression: Production, functionality, critical material attributes and co-processed excipients.

  2025cites this paper
• Optimizing clarification processes in biopharmaceutical manufacturing through quality by design: Strategies, implications, and future prospects

  2025cites this paper
• Smart on-demand drug release strategies for cancer combination therapy.

  2025cites this paper
• Manufacturing in pharmaceuticals: an integrated approach with NIR and Raman as PAT tools.

  2025cites this paper
• Machine learning model-based design and model predictive control of a bioreactor for the improved production of mammalian cell-based bio-therapeutics

  2025cites this paper
• Data-Driven Modeling for the Enhanced Understanding for the Crystallization of an Active Pharmaceutical Ingredient

  2025cites this paper
• Near‐infrared spectroscopy coupled with convolutional neural network as a checkpoint tool for cell culture bioprocess media characterization

  2025cites this paper
• A Scoping Review of Modelling in Target Product Profile Development for Medical Innovation

  2025cites this paper
• Machine learning enhanced process design in protein a chromatography.

  2025cites this paper
• On Digital Twins in Bioprocessing: Opportunities and Limitations

  2025cites this paper
• Chromatography in Downstream Processing of Recombinant Adeno‐Associated Viruses: A Review of Current and Future Practises

  2025cites this paper
• An Automated Tool for Glycosimilarity Assessment of mAb Therapeutic Biosimilars: Trastuzumab and Bevacizumab as Case Studies

  2025cites this paper
• Blockchain-enabled quality by design system for clinical trials

  2025cites this paper
• Different strategies to make biobetters: physicochemical, pharmacodynamics, and pharmacokinetic aspects came into focus.

  2025cites this paper
• Quality by digital design for accelerated sustainable nanomedicine development.

  2025cites this paper
• AI-driven 3D bioprinting for regenerative medicine: From bench to bedside

  2024cites this paper
• Advances in Therapeutic Peptides Separation and Purification

  2024cites this paper
• Status and future developments for downstream processing of biological products

  2024cites this paper
• Soft sensor for viable cell counting by measuring dynamic oxygen uptake rate.

  2024cites this paper
• From protein structure to an optimized chromatographic capture step using multiscale modeling

  2024cites this paper
• Quality by Design Framework Applied to GMMA Purification

  2024cites this paper
• DOE-based process optimization for development of efficient methods for purification of recombinant hepatitis B surface antigen from Pichia pastoris feedstock using Capto adhere resin

  2024cites this paper
• Recent Advances in Intranasal Administration for Brain-Targeting Delivery: A Comprehensive Review of Lipid-Based Nanoparticles and Stimuli-Responsive Gel Formulations

  2024cites this paper
• Antibody glycan quality predicted from CHO cell culture media markers and machine learning

  2024cites this paper
• Overview: flexible and versatile approach of quality by design & process analytical technology in industries

  2024cites this paper
• Model-assisted process development, characterization and design of continuous chromatography for antibody separation.

  2023cites this paper
• Engineers in Medicine: Foster Innovation by Traversing Boundaries.

  2023cites this paper
• Quality by Design (QbD) and Design of Experiments (DOE) as a Strategy for Tuning Lipid Nanoparticle Formulations for RNA Delivery

  2023cites this paper
• A novel system for glycosylation engineering by natural and artificial miRNAs.

  2023cites this paper
• Roadmap for Drug Product Development and Manufacturing of Biologics.

  2023cites this paper
• QUALITY BY DESIGN IMPLEMENTATION IN THE DEVELOPMENT OF DERMATOLOGICAL MEDICINAL PRODUCTS

  2023cites this paper
• Biotechnological Drug Development—The Role of Proteins, Genes, In-Silico, and Stem Cells in Designing Models for Enhanced Drug Discovery

  2023cites this paper
• Question-based review for pharmaceutical development: An enhanced quality approach.

  2023cites this paper
• The Development of Oral Solid Dosage Forms Using the Direct-Compression Tableting of Spray-Dried Bacteriophages Suitable for Targeted Delivery and Controlled Release

  2023cites this paper
• Advanced Manufacturing, Formulation and Microencapsulation of Therapeutic Phages.

  2023cites this paper
• Biopharmaceutical Manufacturing: Historical Perspectives and Future Directions.

  2022cites this paper
• Real-time monitoring of antibody quality attributes for cell culture production processes in bioreactors via integration of an automated sampling technology with multi-dimensional liquid chromatography mass spectrometry.

  2022cites this paper
• Quality by Design Approach in Liposomal Formulations: Robust Product Development

  2022cites this paper
• Reaction mechanism of the green synthesis of glutaric acid

  2022cites this paper
• Determination of culture design spaces in shaken disposable cultivation systems for CHO suspension cell cultures

  2022cites this paper
• Quality by Design for enabling RNA platform production processes.

  2022cites this paper
• Employing QbD strategies to assess the impact of cell viability and density on the primary recovery of monoclonal antibodies

  2022cites this paper
• mD-UPLC-MS/MS: Next Generation of mAb Characterization by Multidimensional Ultraperformance Liquid Chromatography-Mass Spectrometry and Parallel On-Column LysC and Trypsin Digestion

  2022cites this paper
• A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA

  2022cites this paper
• Quality by Design (QbD) application for the pharmaceutical development process

  2022influential citation
• Development of a robust multi-attribute method suitable for implementation in a QC environment Biotechnology

  2022cites this paper
• Quality by Design (QbD) Approach in Marketing Authorization Procedures of Non-Biological Complex Drugs: A Critical Evaluation.

  2022cites this paper
• Recent Advances in Deep Eutectic Solvents as Shale Swelling Inhibitors: A Comprehensive Review

  2022cites this paper
• Analysis of Biologics Molecular Descriptors towards Predictive Modelling for Protein Drug Development Using Time-Gated Raman Spectroscopy

  2022cites this paper
• Optimization of a mAb production process with regard to robustness and product quality using quality by design principles

  2022cites this paper
• Taking the individual bias out of examining comparability of biosimilars: A case study on monoclonal antibody therapeutics.

  2022cites this paper
• Retrospective quality by design r(QbD) for lactose production using historical process data and design of experiments

  2022cites this paper
• Development of a Quantitative Chromatographic Fingerprint Analysis Method for Sugar Components of Xiaochaihu Capsules Based on Quality by Design Concept

  2022cites this paper
• Metrological requirements for biomedical device assessment and their ethical implications

  2022cites this paper
• Recent advances to accelerate purification process development: A review with a focus on vaccines.

  2022cites this paper
• Design of Experiments for the Development of Topical Drug Products

  2021cites this paper
• Quality by design to define critical process parameters for mesenchymal stem cell expansion.

  2021cites this paper
• PROSPECTS AND CHALLENGES OF PHARMACEUTICAL BIOTECHNOLOGY

  2021cites this paper
• Novel Strategy for the Calorimetry-Based Control of Fed-Batch Cultivations of Saccharomyces cerevisiae

  2021cites this paper
• Quality by Design

  2021cites this paper
• Chemometrics in Bioanalytical Chemistry

  2021cites this paper
• Control of Continuous Manufacturing Processes for Production of Monoclonal Antibodies

  2021cites this paper
• Towards Biomanufacturing of Cell-Derived Matrices

  2021cites this paper
• Deliquescence Behavior of Deep Eutectic Solvents

  2021cites this paper
• Explicating the Applications of Quality by Design Tools in Optimization of Microparticles and Nanotechnology Based Drug Delivery Systems

  2021cites this paper
• Industrial Monitoring of Cell Culture

  2021cites this paper
• Impact of Critical Material Attributes (CMAs)-Particle Shape on Miniature Pharmaceutical Unit Operations

  2021cites this paper
• Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience

  2021cites this paper
• White paper on high‐throughput process development for integrated continuous biomanufacturing

  2021cites this paper
• Multi-dimensional LC-MS: the next generation characterization of antibody-based therapeutics by unified online bottom-up, middle-up and intact approaches.

  2021cites this paper
• Complete or periodic continuity in continuous manufacturing platforms for production of monoclonal antibodies?

  2021cites this paper
• Build a Sustainable Vaccines Industry with Synthetic Biology

  2021influential citation
• Cyclodextrins as modulators for separation of charged variants of mAbs by capillary zone electrophoresis

  2021cites this paper
• Characterization of hydrodynamic stress in ambr250® bioreactor system and its impact on mammalian cell culture

  2021cites this paper
• Downstream bioprocessing of human pluripotent stem cell‐derived therapeutics

  2021cites this paper
• Applications of capillary electrophoresis for biopharmaceutical product characterization

  2021cites this paper
• Nanomedicine from amphiphilizedprodrugs: concept and clinical translation.

  2021cites this paper
• Control of surge tanks for continuous manufacturing of monoclonal antibodies

  2021cites this paper
• QUALITY BY DESIGN APPROACH: REGULATORY NEED, CURRENT, AND FUTURE PERSPECTIVE

  2021cites this paper
• A Novel Spherical Crystallization Method Using Pickering Emulsions.

  2021cites this paper
• The Multi-Attribute Method (MAM) for the Characterization of Biopharmaceuticals

  2021cites this paper
• Assessment of quality attributes for adeno‐associated viral vectors

  2021cites this paper
• High-Throughput Process Development: I-Process Chromatography.

  2021cites this paper
• Use of Recombinant Endolysin to Improve Accuracy of Group B Streptococcus Tests

  2021cites this paper
• Design of Experiments for Critical Material Attributes Assessment of Linagliptin and Metformin Fixed-dose Combination Tablets

  2021cites this paper
• Process analytics 4.0: A paradigm shift in rapid analytics for biologics development

  2021cites this paper
• A comparison study of Lipid and Polymeric Nanoparticles in the Nasal Delivery of Meloxicam: Formulation, Characterization, and In-Vitro Evaluation.

  2021cites this paper
• Comparison of Raman and MIR spectroscopy for bioprocess monitoring of mammalian cell cultures

  2021cites this paper
• Bioprocess Control: Current Progress and Future Perspectives

  2021cites this paper
• Particle design of the metastable form of clopidogrel hydrogen sulfate by building spherulitic growth operating spaces in binary solvent systems

  2021cites this paper
• Model‐based workflow for scale‐up of process strategies developed in miniaturized bioreactor systems

  2021cites this paper
• Determining the relative importance of titania nanotubes characteristics on bone implant surface performance: A quality by design study with a fuzzy approach.

  2020cites this paper
• Innovator Biologics, Biosimilars, and Biobetters

  2020cites this paper
• Articulation of Quality By Design Elements for Product Development and its Unique Applications

  2020cites this paper
• Perfusion Mammalian Cell Culture for Recombinant Protein Manufacturing

  2020cites this paper
• QbD based approach for formulation development of spray dried microparticles of erlotinib hydrochloride for sustained release

  2020cites this paper
• Working within the Design Space: Do Our Static Process Characterization Methods Suffice?

  2020cites this paper
• Development of Alginate- Neusilin US2 (Magnesium alumino-metasilicate) micro-composite hydrogel beads for oral sustained release of cilnidipine: a statistical optimization

  2020cites this paper
• High Pressure Homogenizer in Pharmaceuticals: Understanding Its Critical Processing Parameters and Applications

  2020cites this paper